These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18708697)

  • 1. A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.
    Mazzarino M; Fiacco I; de la Torre X; Botrè F
    Eur J Mass Spectrom (Chichester); 2008; 14(3):171-80. PubMed ID: 18708697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
    Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
    Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control.
    Mazzarino M; de la Torre X; Botrè F
    Anal Bioanal Chem; 2011 Aug; 401(2):529-41. PubMed ID: 21380606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.
    Lu J; Wang X; Xu Y; Dong Y; Yang S; Wu Y; Qin Y; Wu M
    Analyst; 2011 Feb; 136(3):467-72. PubMed ID: 21113546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approach based on immunochemical techniques for monitoring of selective estrogen receptor modulators (SERMs) in human urine.
    Salvador JP; Vila-Roca E; Monfort N; Ventura R; Marco MP
    J Pharm Biomed Anal; 2018 Jul; 156():147-152. PubMed ID: 29704771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
    Mazzarino M; Braganò MC; de la Torre X; Molaioni F; Botrè F
    Steroids; 2011 Nov; 76(12):1400-6. PubMed ID: 21745489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses.
    Gómez C; Pozo OJ; Diaz R; Sancho JV; Vilaroca E; Salvador JP; Marco MP; Hernandez F; Segura J; Ventura R
    J Chromatogr A; 2011 Jul; 1218(29):4727-37. PubMed ID: 21683367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry.
    Mazzarino M; de la Torre X; Di Santo R; Fiacco I; Rosi F; Botrè F
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):749-60. PubMed ID: 20187079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro phase I metabolism of selective estrogen receptor modulators in horse using ultra-high performance liquid chromatography-high resolution mass spectrometry.
    Kwok KY; Chan GHM; Kwok WH; Wong JKY; Wan TSM
    Drug Test Anal; 2017 Sep; 9(9):1349-1362. PubMed ID: 28054434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites.
    Strano-Rossi S; Colamonici C; Botrè F
    Rapid Commun Mass Spectrom; 2007; 21(2):79-88. PubMed ID: 17154357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry.
    Lu J; He G; Wang X; Xu Y; Wu Y; Dong Y; He Z; Liu X; Bo T; Ouyang G
    J Chromatogr A; 2012 Jun; 1243():23-32. PubMed ID: 22579489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toremifene metabolism in rat, mouse and human liver microsomes: identification of alpha-hydroxytoremifene by LC-MS.
    Jones RM; Lim CK
    Biomed Chromatogr; 2002 Aug; 16(5):361-3. PubMed ID: 12210510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatographic-atmospheric pressure ionization mass spectrometric analysis of toremifene metabolites in human urine.
    Watanabe N; Irie T; Koyama M; Tominaga T
    J Chromatogr; 1989 Dec; 497():169-80. PubMed ID: 2533932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural elucidation of new urinary tamoxifen metabolites by liquid chromatography quadrupole time-of-flight mass spectrometry.
    Lu J; He C; He G; Wang X; Xu Y; Wu Y; Dong Y; Ouyang G
    J Mass Spectrom; 2014 Jul; 49(7):570-8. PubMed ID: 25044841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
    Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of clomiphene metabolite isomers in human plasma by rapid-resolution liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Ganchev B; Heinkele G; Kerb R; Schwab M; Mürdter TE
    Anal Bioanal Chem; 2011 Jul; 400(10):3429-41. PubMed ID: 21533795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of tamoxifen urinary metabolites in rat by ultra-high-performance liquid chromatography time-of-flight mass spectrometry.
    Domínguez-Romero JC; García-Reyes JF; Beneito-Cambra M; Martínez-Romero R; Martinez-Lara E; Del Moral-Leal ML; Molina-Díaz A
    Biomed Chromatogr; 2015 Aug; 29(8):1220-8. PubMed ID: 25611330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction.
    Sobolevsky T; Ahrens B
    Drug Test Anal; 2021 Feb; 13(2):283-298. PubMed ID: 32852861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents.
    Ventura R; Roig M; Montfort N; Sáez P; Bergés R; Segura J
    Eur J Mass Spectrom (Chichester); 2008; 14(3):191-200. PubMed ID: 18708699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
    Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.